Draper Esprit Aktie 30782172 / GB00BY7QYJ50
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
29.10.2025 08:00:17
|
Notice of Half Year Results Presentations
|
Molten Ventures Plc (GROW)
29 October 2025 Molten Ventures plc Notice of Half Year Results Presentations Molten Ventures (LSE: GROW), a leading venture capital firm investing in and developing high-growth digital technology businesses, announces details of presentations to accompany its half year results for the six months ended 30 September 2025 being announced on Tuesday, 25 November 2025.
A presentation for analysts and other registered investment professionals will be held at 09:30am GMT on Tuesday, 25 November 2025, both in-person at Molten’s London office and virtually. To register to attend in-person, please contact Sodali on molten@sodali.com. To register to attend virtually, please visit: https://stream.brrmedia.co.uk/broadcast/68fb4c429f0c7e00132b04c4
Molten will also be hosting a presentation on Friday, 5 December 2025 at 10:30am GMT via the Investor Meet Company platform. The presentation is open to all existing and potential shareholders, with a live Q&A session. Questions can be submitted pre-event via the Investor Meet Company dashboard or at any time during the presentation. Investors can sign up for the event for free via this link: https://www.investormeetcompany.com/molten-ventures-plc/register-investor
Enquiries:
Molten Ventures is a leading venture capital firm in Europe, developing and investing in high growth technology companies. It invests across four sectors: Enterprise & SaaS; AI, Deeptech & Hardware; Consumer Technology; and Digital Health with highly experienced partners constantly looking for new opportunities in each. Listed on the London Stock Exchange, Molten Ventures provides a unique opportunity for public market investors to access these fast-growing tech businesses, without having to commit to long term investments with limited liquidity. Since its IPO in June 2016, Molten has deployed over £1bn capital into fast growing tech companies and has realised more than £700m to 30 September 2025. For more information, go to https://investors.moltenventures.com/investor-relations/plc
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | GB00BY7QYJ50 |
| Category Code: | NOR |
| TIDM: | GROW |
| LEI Code: | 213800IPCR3SAYJWSW10 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 406479 |
| EQS News ID: | 2220074 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Draper Esprit PLC
|
30.10.25 |
Transaction in Own Shares (EQS Group) | |
|
29.10.25 |
Notice of Half Year Results Presentations (EQS Group) | |
|
29.10.25 |
Transaction in Own Shares (EQS Group) | |
|
28.10.25 |
Transaction in Own Shares (EQS Group) | |
|
24.10.25 |
Holding(s) in Company (EQS Group) | |
|
24.10.25 |
Transaction in Own Shares (EQS Group) | |
|
23.10.25 |
Transaction in Own Shares (EQS Group) | |
|
23.10.25 |
Half Year Trading Update (EQS Group) |
Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall
Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.
Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.
🎯 Themen im Interview mit Etienne Jornod (OM Pharma)
– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Draper Esprit PLC | 5.50 | 0.00% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach EZB-Zinsentscheid: SMI und DAX letztlich wenig bewegt -- Wall Street schliessen tiefer -- Märkte in Fernost zum Handelsende uneinsAm heimischen sowie am deutschen Aktienmarkt hielten sich Anleger zurück. An der Wall Street ging es nach unten. Die wichtigsten asiatischen Börsen wiesen am Donnerstag verschiedene Vorzeichen aus.